Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone.

To evaluate the recovery of the hypothalamic-pituitary-adrenal (HPA) axis after discontinuation of prolonged exposure to glucocorticoids, we employed adult male Sprague-Dawley rats which were implanted sc with osmotic minipumps filled with saline (vehicle) or dexamethasone (DEX), 100 micrograms/day, for 7 days. At the end of the glucocorticoid treatment period, the minipumps were removed and both saline- and DEX-treated rats were randomly assigned to five different groups tested at 1, 3, 7, 14, and 21 days after removal of the minipumps. Each group was divided into two subgroups receiving either arecoline (ARE), or ovine CRH (oCRH) stimulation tests. ARE was chosen because it has been shown to selectively stimulate the hypothalamic CRH neuron, whereas oCRH was selected as a probe of the pituitary component of the HPA axis. ARE (0.2 mg/kg) and oCRH (10 micrograms/kg) were injected iv to catheterized, freely moving rats and serial blood samples for plasma ACTH and corticosterone determinations were drawn from the catheter before, and 5, 15, 30, and 60 min after the injection. The day after the tests were performed, the rats were killed by decapitation, and body, adrenal and thymus weights, as well as hypothalamic CRH and pituitary ACTH content were determined. On the day of the stimulation tests, basal plasma levels of ACTH and corticosterone were not different between saline- and DEX-treated rats at any time-point after discontinuation of treatment. The ACTH response to ARE, on the other hand, was suppressed one day after, but became normal 3 days after discontinuation of DEX treatment. ACTH response to oCRH normalized later, after 7 days. Interestingly, corticosterone responses to both ARE and oCRH normalized 7 days after discontinuation of glucocorticoid administration. Body, adrenal and thymus weights were significantly reduced by DEX treatment. They recovered slowly and only after 22 days there was no difference between DEX- and saline-treated rats in body and adrenal weight. In contrast, thymus weight was still low on day 8, began to increase after 15 days, and by day 22 did not reach the values recorded in saline-treated rats. Hypothalamic immunoreactive CRH content was not different between DEX- and saline-treated rats, whereas the content of ACTH in the pituitary gland was lower in the DEX-treated rats the second day after discontinuation of GC treatment, normalized after 4 days and increased significantly after 8 days.(ABSTRACT TRUNCATED AT 400 WORDS)

[1]  D. Murphy,et al.  Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. , 1989, Endocrinology.

[2]  E. O. Johnson,et al.  The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism. , 1989, Endocrinology.

[3]  R. W. Kuhn,et al.  Pharmacological evidence that the inhibition of diurnal adrenocorticotropin secretion by corticosteroids is mediated via type I corticosterone-preferring receptors. , 1989, Endocrinology.

[4]  M. Dallman,et al.  The adrenocortical system responds slowly to removal of corticosterone in the absence of concurrent stress. , 1989, Endocrinology.

[5]  P. Munson,et al.  Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami , 1989, Peptides.

[6]  G. Chrousos,et al.  Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications. , 1988, The Journal of clinical investigation.

[7]  E. D. Kloet,et al.  Feedback action and tonic influence of corticosteroids on brain function: A concept arising from the heterogeneity of brain receptor systems , 1987, Psychoneuroendocrinology.

[8]  G. Chrousos,et al.  The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome. , 1987, The Journal of clinical endocrinology and metabolism.

[9]  N. Kalin,et al.  Effects of dexamethasone on central and peripheral ACTH systems in the rat. , 1987, Neuroendocrinology.

[10]  E. R. Kloet,et al.  Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. , 1985, Endocrinology.

[11]  H. Imura,et al.  Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/beta-lipotropin precursor mRNA in the pituitary in rats. , 1985, Endocrinology.

[12]  J. Doppman,et al.  Clinical Applications of Corticotropin-Releasing Factor , 1985 .

[13]  G. Chrousos,et al.  The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. , 1984, The New England journal of medicine.

[14]  T. Suda,et al.  Effect of dexamethasone on immunoreactive corticotropin-releasing factor in the rat median eminence and intermediate-posterior pituitary. , 1984, Endocrinology.

[15]  J. Vaughan,et al.  [38] Assay of corticotropin releasing factor , 1983 .

[16]  D. Aron,et al.  Cushing's disease: transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin. , 1982, The Journal of clinical endocrinology and metabolism.

[17]  S. Feldman,et al.  Participation of the dorsal hippocampus in the glucocorticoid feedback effect on adrenocortical activity. , 1980, Neuroendocrinology.

[18]  M. Brownstein,et al.  Corticotropin releasing factor distribution in normal and Brattleboro rat brain, and effect of deafferentation, hypophysectomy and steroid treatment in normal animals. , 1977, Endocrinology.

[19]  M. Greer,et al.  Rat hypothalamic corticotropin-releasing factor (CRF) content remains constant despite marked acute or chronic changes in ACTH secretion. , 1976, Neuroendocrinology.

[20]  E. R. Kloet,et al.  The site of the suppressive action of dexamethasone on pituitary-adrenal activity. , 1974 .

[21]  S. Feldman,et al.  Effects of Corticosteroids on Hypothalamic Corticotropin Releasing Factor and Pituitary ACTH Content , 1967 .

[22]  J. Vernikos-Danellis.  EFFECT OF STRESS, ADRENALECTOMY, HYPOPHYSECTOMY AND HYDROCORTISONE ON THE CORTICOTROPIN-RELEASING ACTIVITY OF RAT MEDIAN EMINENCE. , 1965, Endocrinology.

[23]  W. Nicholson,et al.  NATURAL HISTORY OF PITUITARY-ADRENAL RECOVERY FOLLOWING LONG-TERM SUPPRESSION WITH CORTICOSTEROIDS. , 1964, Transactions of the Association of American Physicians.

[24]  K. Knigge,et al.  Adrenocortical Response to Stress in Rats with Lesions in Hippocampus and Amygdala.∗ , 1961, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.